← Back to blog

When a GLP-1 Doesn't Work or You Can't Tolerate It: New Data on Bariatric Surgery

GLP-1 medications work well for many people, but not for everyone. Some people cannot tolerate the side effects, and others stay on treatment without losing enough weight. A Cleveland Clinic study published November 3, 2026 in Annals of Surgery looked at what happens when those patients move on to bariatric surgery.

What the researchers did

The team studied 4,929 adults who had bariatric surgery at Cleveland Clinic hospitals in Ohio between 2018 and 2024, and split them into three groups:

  • 4,661 people who had never taken semaglutide or tirzepatide
  • 61 people who stopped one of those drugs because of intolerable side effects
  • 207 people who lost too little weight while taking one of them

Median body weight at the time of surgery ranged from about 273 to 287 pounds across the groups.

What they found

The patients who saw little or no benefit from the medications lost about 2% of their body weight or less within two years of starting them. After surgery, two-year total weight loss looked like this. The lower number is gastric sleeve and the higher is gastric bypass:

  • Stopped the medication because of side effects: about 23% to 26%
  • Lost too little on the medication: about 18% to 33%
  • Never took either medication: about 24% to 33%

In several groups the results were comparable to people who had never used a GLP-1. The researchers reported low complication rates for both operations.

Limits to keep in mind

This was an observational study at one health system. The medication groups were small, with only 61 people in the side-effect group. Follow-up stopped at two years, and the researchers could not confirm how consistently people took their medication. The authors also stress that the results do not mean surgery is the right next step for everyone who struggles with these drugs. Decisions should fit each person's health, history and preferences.

Why it matters

Earlier research has found that roughly half of patients in real-world practice stop these medications within a year. For them, a poor response or a rough start on a drug does not have to be the end of treatment. Lead author Ali Aminian described surgery and medication as complementary tools rather than competing approaches.

If this sounds like you

  • Before deciding a medication has failed, ask your provider whether dose, timing, protein intake or adherence could be playing a part.
  • Ask about your options: a different medication, added therapy, or a bariatric surgery consultation.
  • Keep a record of your dose dates, weight trend and side effects over several weeks. It gives your clinician real data to work from.

This article summarizes a published research announcement for general information and is not medical advice. Content was rephrased for compliance. Discuss treatment options with your healthcare provider.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment protocol.